B. Braun expands production in Sempach

The pharmaceutical device manufacturer B. Braun is doubling its capacity to produce disinfectants in Sempach. Overall, it aims to invest 70 million Swiss francs. According to CEO Roman Kübler, the expansion is a clear commitment to Switzerland as a location.

construction site
From left to right: Dionne G. Bussell, Bernhard Kobler, Anne Schwoebel, Roman Kuebler, Reto Fleischlin. Image Credit: B. Braun

B. Braun’s disinfection competence center is located in Sempach, where research, development and production is conducted in this area. According to a press release, the company now aims to double the production capacity at this site. It is investing around 70 million Swiss francs into a new factory called the N.I.C.O. (New Infection Control Organization).

B. Braun explains that the demand for disinfectants has increased over recent years. This development has now been accelerated by the current coronavirus crisis.

According to Roman Kübler, CEO of B. Braun Switzerland, Sempach is “a very successful site with an excellent infrastructure and loyal, qualified staff.” He stresses that B. Braun is “still confident in Switzerland as a location” with “favorable conditions for employers, a high standard of education and not least political stability” offering “very valuable benefits” for the company in both the short and long term.

Construction work on the new factory is scheduled to start in summer and should take around two years.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

How should we contact you?

Premium Partner

Strategic partners

Institutional partner

Official program